Quest for immunological biomarkers in the management of CHB patients
- PMID: 36922017
- DOI: 10.1136/gutjnl-2023-329437
Quest for immunological biomarkers in the management of CHB patients
Keywords: CELLULAR IMMUNOLOGY; CHRONIC VIRAL HEPATITIS; HEPATITIS B; IMMUNOTHERAPY.
Conflict of interest statement
Competing interests: AB and NLB reported a patent for a method to monitor SARS-CoV-2-specific T cells in biological samples pending and are the co-founders of T Cell Diagnostic (TCD).
Comment on
-
Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro.Gut. 2023 Nov;72(11):2123-2137. doi: 10.1136/gutjnl-2022-327202. Epub 2023 Jan 30. Gut. 2023. PMID: 36717219 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources